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Summary
Reactive oxygen species (ROS) are potent inducers of
oxidative damage and have been implicated in the regu-
lation of specific cellular functions, including apoptosis.
Mitochondrial ROS increase markedly after proapoptotic
signals, though the biological significance and the un-
derlying molecular mechanisms remain undetermined.
P66Shc is a genetic determinant of life span in mammals,
which regulates ROS metabolism and apoptosis. We re-
port here that p66Shc is a redox enzyme that generates
mitochondrial ROS (hydrogen peroxide) as signaling
molecules for apoptosis. For this function, p66Shc uti-
lizes reducing equivalents of the mitochondrial electron
transfer chain through the oxidation of cytochrome c.
Redox-defective mutants of p66Shc are unable to in-
duce mitochondrial ROS generation and swelling in
vitro or to mediate mitochondrial apoptosis in vivo.
These data demonstrate the existence of alternative
redox reactions of the mitochondrial electron transfer
chain, which evolved to generate proapoptotic ROS
in response to specific stress signals.
Introduction
Apoptosis is essential for the maintenance of tissue ho-
meostasis, and its deregulation is implicated in cancer,*Correspondence: marco.giorgio@ifom-ieo-campus.it; piergiuseppe.
pelicci@ifom-ieo-campus.it
8 These authors contributed equally to this work.degenerative diseases, and aging. Mitochondria play a
central role in apoptosis. They contain a number of pro-
apoptotic factors, such as cytochrome c (cyt c), aif,
smac/diablo, and endoG, which are released into the
cytosol during apoptosis, where they activate a series
of enzymatic activities that lead to the specific degra-
dation of proteins and DNA (Danial and Korsmeyer,
2004; Pelicci, 2004).
The release of proapoptotic factors from mito-
chondria is due to the disruption of the organelle integ-
rity, which is achieved through multiple and concomi-
tant events. In the case of cyt c, for example, its release
requires permeabilization of the outer membrane, re-
modeling of the mitochondrial cristae, and dissociation
of cyt c from cardiolipin, a constituent of the inner
membrane (Green and Kroemer, 2004). These events
are triggered by the opening of a high-conductance
channel, the permeability transition pore (PTP) (Ber-
nardi et al., 2001). Opening of the PTP provokes an
increase of inner membrane permeability to ions and
solutes (the so-called permeability transition, PT), fol-
lowed by net water influx toward the mitochondrial ma-
trix, swelling of the organelle, and physical rupture of its
outer membrane, with the consequent release of proteins
of the intermembrane space, including cyt c (Bernardi
et al., 2001). Another mechanism leading to alterations
of the mitochondrial membrane integrity is the translo-
cation of proapoptotic proteins such as Bax and Bid
from the cytosol to the outer mitochondrial membrane,
where they form channels and/or regulate the function
of preexisting channels (Scorrano and Korsmeyer,
2003). Whether these events then trigger the PT or are
per se sufficient to mediate complete cyt c release re-
mains, however, controversial.
Reactive oxygen species (ROS; superoxide, hydro-
gen peroxide, and hydroxyl radicals) are potent intra-
cellular oxidants, which have been proposed as critical
regulators of apoptosis (Danial and Korsmeyer, 2004).
Indeed, ROS induce the opening of the PTP through
oxidation-dependent mechanisms and are potent in-
ducers of apoptosis, both in cultured cells and in vivo
(Petronilli et al., 1994; Danial and Korsmeyer, 2004). Be-
yond their documented proapoptotic activity when ad-
ministered exogenously, endogenously produced ROS
are implicated in the execution of the apoptotic pro-
gram itself, regardless of the type of triggering signal.
In fact, a marked increase of intracellular ROS is con-
sistently associated with apoptosis, and treatments
with antioxidants protect cells from apoptosis (Mayer
and Noble, 1994).
The molecular mechanisms underlying increased
ROS generation during apoptosis are unclear. It has
been proposed that ROS accumulation is secondary to
the progress of the apoptotic process and is caused by
the interruption of the mitochondrial electron transfer
chain (ETC), a consequence of the PT and of cyt c re-
lease (Cai and Jones, 1998). Alternatively, ROS might
function to trigger mitochondrial apoptosis, serving as
signaling molecules to initiate the PT. Notably, intracel-
lular ROS arise prior to cyt c release during the acti-
Cell
222vation of several apoptotic pathways, such as those h
involving p53 or TNFα or those triggered by hypergly- p
cemia, ischemia/reperfusion, or viral infection (Trinei et
al., 2002; Sakon et al., 2003; Brownlee, 2001; Becker, R
2004).
ROS are generated accidentally, as by products of P
aerobic metabolism, and mitochondria are the major o
source of intracellular ROS (Wallace, 1999). During res- T
piration, electrons are extracted from substrates and c
are then transferred to molecular oxygen through a s
chain of enzymatic complexes (I–IV). In the final step of c
the ETC, cyt c oxidase (COX; complex IV) ensures the M
reduction of molecular oxygen to water, without forma- l
tion of oxygen radicals. However, partial reduction of (
oxygen with generation of ROS can occur if molecular t
oxygen interacts with the ETC upstream of complex IV. 2
Experimental data indicate that ROS are indeed contin- n
uously produced during mitochondrial respiration and C
that up to 2% of the total oxygen consumption is con- (
verted to ROS (Chance et al., 1979). How ROS are regu- c
lated during apoptosis is unclear. c
P66Shc deletion in mice (p66Shc−/−) decreases the in- m
cidence of aging-associated diseases, such as athero-
sclerosis, and prolongs life span (Migliaccio et al., 1999; w
Napoli et al., 2003; Francia et al., 2004). The underlying i
molecular mechanisms are, however, unknown. P66Shc m
is a splice variant of p52Shc/p46Shc, two cytoplasmic 
adaptor proteins involved in the propagation of intracel- b
lular signals from activated tyrosine kinases to Ras d
(Pelicci et al., 1992). P66Shc has the same modular a
structure of p52Shc/p46Shc (SH2-CH1-PTB) and con- [
tains a unique N-terminal region (CH2); however, it is a
not involved in Ras regulation but rather functions in d
the intracellular pathway(s) that regulates ROS metabo- T
lism and apoptosis (Migliaccio et al., 1997; Migliaccio s
et al., 1999; Trinei et al., 2002). t
Intracellular ROS levels are decreased in p66Shc−/− m
cells, as revealed by the reduced oxidation of ROS-sen-
c
sitive probes and the reduced accumulation of endoge-
R
nous markers of oxidative stress (8-oxo-guanosine)
i(Trinei et al., 2002; Francia et al., 2004). Likewise,
wp66Shc−/− mice have diminished levels of both systemic
A(isoprostane) and intracellular (nytrotyrosines, 8-oxo-
pguanosine) oxidative stress (Napoli et al., 2003; Francia
aet al., 2004; Trinei et al., 2002).
nP66Shc−/− cells are resistant to apoptosis induced by
pa variety of different signals, including hydrogen perox-
mide, ultraviolet radiation, staurosporine, growth factor
Pdeprivation, calcium ionophore, and CD3-CD4 cross-
linking (Migliaccio et al., 1999; Orsini et al., 2004; Pacini
Pet al., 2004). Similarly, the p66Shc−/− mice are resistant
Ito apoptosis induced by paraquat, hypercholestero-
Plemia, and ischemia (Migliaccio et al., 1999; Napoli et
cal., 2003; Zaccagnini et al., 2004).
tExpression of p66Shc is indispensable for the mi-
ttochondrial depolarization and the release of cyt c
(observed after treatment of cells with various proapo-
iptotic signals, suggesting that it regulates the mito-
echondrial pathway of apoptosis. Since inhibition of PTP
topening blocks the proapoptotic function of p66Shc, the
lPTP itself might be the target of p66Shc activity (Trinei
aet al., 2002; Orsini et al., 2004). We report here that
p66Shc is a redox enzyme that generates mitochondrial tydrogen peroxide for the induction of PT and apo-
tosis.
esults
66Shc Induces Permeability Transition
f Isolated Mitochondria
o investigate whether the effect of p66Shc on the mito-
hondrial PTP is direct, we analyzed its ability to induce
welling of purified mitochondria, measured as de-
rease of light absorbance of the organelle suspension.
itochondria were purified from wild-type (wt) mouse
iver and pretreated with a low concentration of Ca2+
7 M), a condition that does not induce PT but sensi-
izes PTP opening to other signals (Bernardi et al.,
001). Addition of recombinant p66Shc (5–20 M) did
ot induce swelling, as compared to a large load of
a2+ (0.2 mM), a well-characterized inducer of the PT
Figure 1A). Since p66Shc is not imported by mito-
hondria in vitro (Ventura et al. 2004), this finding indi-
ates that p66Shc is unable to alter mitochondrial per-
eability when acting from the outside of the organelle.
We then investigated the effect of p66Shc on the PTP
hen the protein is allowed to enter the mitochondrial
ntermembrane space. To this end, we treated purified
itochondria with a low concentration of digitonin (25
M), which selectively permeabilizes the outer mem-
rane without affecting PT, as shown by the fact that
igitonin-treated mitochondria retain cyt c, respire, and
re sensitive to Ca2+-induced swelling (Diwan et al.
1988] and data not shown). Under these conditions,
ddition of recombinant p66Shc induced marked and
ose-dependent swelling of mitochondria (Figure 1B).
his effect was abolished in the absence of respiratory
ubstrates, indicating that it depends on an intact
ransmembrane potential (data not shown). Further-
ore, it was Ca2+ dependent (data not shown) and
omparable to that obtained by exogenously added
OS (H2O2; Figure 1C). Notably, p66Shc was unable to
nduce swelling when digitonin-treated mitochondria
ere pretreated with PT inhibitors such as cyclosporine
(CsA), a drug that binds the PTP component cyclo-
hilin D, or N-ethyl-maleimide (NEM), a sulfhydryl re-
gent that blocks PTP opening by thiol oxidants (Petro-
illi et al., 1994) (Figure 1D). These results suggest that
66Shc is biologically active when it localizes within the
itochondrial intermembrane space, where it induces
T through oxidation-dependent mechanisms.
66Shc Localizes within the Mitochondrial
ntermembrane Space
66Shc is enriched in the submitochondrial fraction
ontaining inner membranes (Orsini et al., 2004). To fur-
her investigate its localization, mitochondria prepara-
ions from MEFs (Figure 1E) were treated with digitonin
which allows extraction of soluble proteins from the
ntermembrane space) or digitonin and high salt (which
xtracts membrane bound proteins). After centrifuga-
ion, the resulting pellets and supernatants were ana-
yzed by Western blotting (WB) by using anti-p66Shc,
nti-cyt c, anti-mtHsp70, or anti-porin antibodies. Digi-
onin or digitonin/high-salt treatments did not modify
P66Shc Is a Redox Enzyme that Generates H2O2
223Figure 1. P66Shc Localizes within the Mito-
chondrial Intermembrane Space and In-
duces Swelling of Isolated Mitochondria
Absorbance changes of purified liver mito-
chondria, either intact (A) or treated with 25
M digitonin (B–D), pretreated with 7 M
CaCl2 and supplemented with the following:
(A) 20 M collagenase as inactive control
(control [ctrl]; black trace), 20 M p66Shc
(red), or 200 M CaCl2 (brown); (B) 20 M
collagenase in 0.25 M sucrose (ctrl, black) or
different concentrations of p66Shc (5, 10, and
20 M, as indicated; red); (C) different con-
centrations of H2O2 (blue) or control buffer
(gray); (D) 20 M p66Shc (added to all kine-
tics) and 1 M CsA (violet), 20 M NEM
(green) or control buffer (red). Each experi-
ment was performed six times using different
mitochondrial preparations and two distinct
preparations of the p66Shc. (E) (Left panels)
WB analysis of MEF subcellular fractions
using anti-p66Shc, anti-mtHp70, anti-cal-
nexin, and anti-cytoplasmic Hsp70 antibod-
ies. T, total extract; Mt, mitochondria; ER,
endoplasmic reticulum; Ct, cytosol. (Right
panels) ER and Mt fractions were treated
with Proteinase K (PK) and analyzed by WB
with anti-calnexin or anti-p66Shc antibodies.
(F and G) Mitochondrial fractions from MEFs
were treated with the indicated concentra-
tions of NaCl and/or digitonin. After centrifu-
gation, pellets (P) and supernatants (S) were
analyzed by WB.the localization of porin (a marker of the outer mem-
brane) and of mtHsp70 (matrix), indicating that these
experimental conditions did not provoke gross struc-
tural alterations of purified mitochondria (Figures 1F
and 1G). As expected, digitonin/high salt but not digi-
tonin alone induced cyt c release in the supernatant
(Griparic et al., 2004). P66Shc, instead, was partially and
equally released by either digitonin or digitonin/high
salt, suggesting that it exists within the inner mitochon-
drial space in the form of both soluble and nonsoluble
protein (mitochondrial p66Shc is about 50 ng/mg of total
proteins; see Figure S1 in the Supplemental Data avail-
able with this article online). Similar results were ob-
tained by morphometric analysis of immunoelectron
microscopy sections of wt MEFs, which revealed asso-
ciation of mitochondrial gold particles with the inner
membrane (55.7%), intermembrane space (35.4%), and
matrix (8.9%) (data not shown).P66Shc Stimulates Generation of ROS
by Energized Mitochondria
P66Shc expression is indispensable for the upregulation
of intracellular ROS during p53- or ischemia-induced
apoptosis (Trinei et al., 2002; Pacini et al., 2004; Zac-
cagnini et al., 2004). To investigate whether p66Shc-reg-
ulated ROS derive from mitochondria, we analyzed in-
tact liver mitochondria from wt or p66Shc−/− mice upon
treatment with carbon tetrachloride (CCl4; 2 mg/kg), a
chemical that induces ROS- and p66Shc-dependent
apoptosis. We had previously shown that in vivo treat-
ment with CCl4 induces apoptosis of hepatocytes in wt
but not p66Shc−/− mice and that apoptosis in wt animals
is prevented by treatment with the antioxidant N-acetyl
cysteine. Likewise, CCl4 induces p66Shc- and ROS-
dependent apoptosis of MEFs (Figure S2). Liver mito-
chondria were collected 20 hr after treatment, and ROS
were measured by spectrofluorimetry, using a mole-
Cell
224cular probe that becomes fluorescent upon oxidation p
Rby ROS (2#,7#-dichlorofluorescin diacetate; H2DCFDA)
(LeBel et al., 1992). The rate of mitochondrial H2DFCDA p
oxidation increased significantly after CCl4 treatment in
the wt mice, while it remained unchanged in the e
fp66Shc−/− mice (Figures 2A–2C). Notably, H2DCFDA oxi-
dation was consistently detected only in the presence s
wof respiratory substrates, such as succinate (Figures
2A–2C) or glutamate/malate (data not shown). Together, S
kthese findings indicate that p66Shc expression is indis-Figure 2. P66Shc Stimulates Mitochondrial Generation of ROS
(A and B) Fluorescence changes (ex. 498, em. 527; I, intensity of fluorescence) and corresponding bar graph (rate of fluorescence intensity/
min) (C) of mitochondria from wt (black lines in [A] and [B] and empty bars in [C]) or p66Shc−/− (red lines and red bars) mouse livers, treated
with placebo ([A], CTRL) or CCl4 ([B], +CCl4), after sequential additions of H2DCFDA and ant A (black and red lines) or control ethanol (gray
line, wt; green line, p66Shc−/−) with (plain) or without (dashed) succinate. (A) and (B) report one set of experiments representative of four; (C)
reports the average of the four experiments ± SEM (#, wt ctrl versus wt +CCl4, p < 0,01; #, p66Shc−/− + CCl4 versus wt + CCl4, p < 0.01).
Respiration was controlled for each mitochondrial preparation. (D) Fluorescence changes (ex. 498, em. 527) of purified liver mitoplasts after
sequential additions of H2DCFDA, succinate and ant A (blue), p66Shc (red), or 20 M collagenase (ctrl, black). (D) reports one set of experi-
ments. The average of six experiments is reported in the graph of the right panel ± SEM, where results are expressed as fold increase in
fluorescence rate induced by p66Shc, ant A, or control buffer (*, p66Shc versus ctrl, p < 0.01). (E) Fluorescence changes (ex. 498, em. 527) of
purified liver mitoplasts after sequential additions of H2DCFDA and succinate (green), p66Shc (red), or ant A (blue). (F) Respiration analysis of
mitoplasts after additions of p66Shc (red), ant A (blue), or control buffer (ctrl, black). ADP (100 m) was added to all samples to maximize
respiration. (G and H) Fluorescence changes in intact wt (black) or p66Shc−/− (red) MEFs incubated with H2DCFDA (G) or HE (ex. 410, em.
490) (H) and treated with ant A (plain) or ethanol as control (dashed).ensable for the increased generation of mitochondrial
OS after challenge with proapoptotic stimuli and that
66Shc requires a functional ETC for this activity.
To analyze the mechanisms underlying the regulatory
ffect of p66Shc on mitochondrial ROS generation, we
irst investigated ROS scavenging. The total peroxide
cavenging activities in mitochondrial preparations from
t and p66Shc−/− mouse livers were comparable (Figure
3). Furthermore, we found no differences in any of the
nown ROS scavenging systems (catalase, SODs, and
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225GSH-peroxidase) in samples from wt or p66Shc−/− fibro-
blasts and tissues (Figure S3), suggesting that the ef-
fect of p66Shc on mitochondrial ROS is due to increased
ROS production rather than diminished scavenging.
The effect of p66Shc on mitochondrial ROS produc-
tion might be direct or, rather, be the consequence of
the organelle swelling induced by p66Shc. To distinguish
between these two possibilities, we investigated the ef-
fect of recombinant p66Shc on ROS generation by puri-
fied mitoplasts. Mitoplasts are unable to swell after PTP
opening, yet they respire (due to a fraction of cyt c that
remains associated to the inner membrane; Figure 2F).
Strikingly, addition of recombinant p66Shc to mitoplasts
increased H2DCFDA oxidation (Figure 2D). These data
indicate that the effect of p66Shc on mitochondrial ROS
production is not a consequence of the organelle swell-
ing and suggest that p66Shc directly stimulates mito-
chondrial ROS generation.
P66Shc Produces Mitochondrial Hydrogen Peroxide
without Inhibiting Respiration
Mitochondrial respiration generates hydrogen peroxide
(H2O2) by dismutation of superoxide anion (O2-·), which
is produced by reduction of oxygen by semiquinone
(Balaban et al., 2005). A well-characterized mechanism
leading to mitochondrial ROS generation is inhibition of
ETC downstream to quinone. Antimycin A (ant A), for
example, blocks the ETC at the level of complex III and
is a potent inducer of O2-· and H2O2 production (Bala-
ban et al., 2005). Therefore, we investigated the effects
of p66Shc on mitochondrial respiration and H2O2/O2-·
metabolism.
Like ant A, p66Shc did not induce ROS production in
nonrespiring mitochondria (data not shown) or mi-
toplasts (Figures 2D and 2E). Unlike ant A, however,
p66Shc did not decrease oxygen consumption of mi-
toplasts (Figure 2F) or mitochondria (data not shown),
indicating that it does not block respiration. To obtain
in vivo confirmation, oxygen consumption was mea-
sured in purified liver and heart mitochondria and in
intact primary fibroblasts from wt and p66Shc−/− mice
under either basal or uncoupled conditions and using
different substrates. In no case did we observe sig-
nificant differences in respiration between wt and
p66Shc−/− mitochondria (data not shown).
To characterize ROS production by p66Shc, we used
H2DCFDA or hydroetidine (HE), two fluorescent probes
that are oxidized by H2O2 or O2-·, respectively (LeBel
et al., 1992; Zhao et al., 2003). Their specificity in our
experimental system was confirmed by the findings
that basal and p66Shc-induced H2DCFDA oxidation by
mitoplasts was inhibited by catalase (an H2O2 scaven-
ger) but not by superoxide dismutase (SOD) (which
generates H2O2 from O2-·), while HE oxidation was in-
hibited by SOD but not by catalase (Figure S4). Analysis
of basal and ant A-induced oxidation of H2DCFDA or
HE in wt and p66Shc−/− MEFs (Figures 2G and 2H) and
purified liver mitochondria (data not shown) revealed
decreased levels of H2O2 but not O2-· in the p66Shc−/−
samples. It appears, therefore, that p66Shc stimulates
H2O2 generation without affecting mitochondrial respi-
ration or production of O2-·. Since, however, it requires
a functional ETC, these data suggest that p66Shc favorsoxygen reduction using reducing equivalents from the
respiratory chain. We estimate the rate of H2O2 produc-
tion by p66Shc in the range of 10 nM/min/mg of mito-
chondrial protein, both in vivo (Figures 2A and 2B)
and in vitro (Figure 2D) (using standard curves of H2O2-
induced H2DFCDA fluorescence in mitoplasts or mito-
chondria suspensions; data not shown).
P66Shc Is a Redox Protein that Mediates
Electron Transfer
We therefore investigated whether p66Shc is capable
itself to execute an electron transfer (ET) reaction. To
this end, we measured the ability of recombinant
p66Shc to mediate ET when adsorbed onto a probe
electrode by cyclic voltammetry (CV) (Armstrong, 2002).
Protein adsorption was performed through the carbox-
ylic group of 11-mercaptoundecanoic acid self-assem-
bled as a monolayer (SAM) onto a gold electrode. In the
absence of adsorbed proteins, the CV curve reflected
the unperturbed and symmetrical capacitive response
of the SAM electrode to alternate oxidation and reduc-
tion scans, which is typical of long-chain alkylthiols
SAMs (Figure 3A, left panel). Accordingly, baseline
subtraction from the oxidation and reduction scans
resulted to zero (Figure 3A upper panel; red line). Strik-
ingly, when the SAM electrode was coated with recom-
binant p66Shc, the two CV scans were modified by the
superimposition of additional oxidation and reduction
events, in the regions of 100 and −170 mV, respectively.
Baseline subtraction resulted in two sharp peaks (Fig-
ure 3A). The intensity of the two peaks was always
proportional to the scan rate (data not shown). Fur-
thermore, the calculated concentration of p66Shc that
contributed to the faradaic ET reaction was about 6
pmol/cm2, consistent with a homogenous and thin
layer of an electrode-coated protein of about 66 kDa.
These data indicate that electrode-coated p66Shc un-
dergoes an ET process.
P66Shc Oxidizes Cyt c In Vitro
The average of the oxidation and reduction peaks is a
direct measure of the redox potential of an ET protein,
which, in the case of p66Shc, is about −35 mV. Among
the redox systems that are present within the mito-
chondria, the redox value of cyt c (17 mV) is one of the
closest to that of p66Shc (Figure 3A and Chen et al.
[2002]). Therefore, we evaluated whether cyt c and
p66Shc can exchange electrons. Absorption of cyt c (but
not of glucose oxidase, used as negative control; data
not shown) on the p66Shc-coated electrode provoked a
dramatic change of its CV response (Figure 3B). First,
the reduction/oxidation peaks typical of p66Shc were no
longer detected, while a novel, single ET event was re-
corded with a redox potential of 10 mV (Figure 3B), dis-
tinct from that of either p66Shc or cyt c alone (Figure
3A). Second, the calculated electrode capacitance of
p66Shc was reduced of about 30% in the presence of
cyt c, suggesting that cyt c formed an additional film
onto the p66Shc-coated SAM electrode. These findings
indicate that p66Shc and cyt c interacted physically and
were integrated in the same ET event. Finally, the re-
duction and oxidation peaks of p66Shc became much
closer in the presence of cyt c (from 270 to 35 mV),
Cell
226Figure 3. Redox Properties of p66Shc and of the p66Shc-Cyt c Couple
(A) CV experiments using uncoated (upper panel, Ctrl), p66Shc (middle panel)-, or cyt c (lower panel)-coated SAM electrodes.
(B) CV experiment using a p66Shc-coated SAM electrode in the presence of cyt c.
(C) Absorption spectrum of reduced cyt c in the presence of 20 M p66Shc (red) or control buffer (black).
(D) Absorbance changes at 550 nm of reduced cyt c in the presence of the indicated concentrations of recombinant p66Shc (red), yeast-
purified COX (green), control buffer (black), or 20 M collagenase (gray line).
(E) Fluorescence changes of a 20 M H2DCFDA solution during the sequential addition of 20 M p66Shc (red) or control buffer (black), 10 M
reduced cyt c, and 50 M CuSO4.
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227ally in the presence of air-saturated buffer (Figure 3F; dase, are essential for the interaction and ET reaction
(F) Current measurement at −100 (accumulation step) or +650 (detection step) mV of the glassy carbon electrode coated with a gel containing
p66Shc and cyt c. Recordings were performed in aerated (air, blue and black traces) or argon-flushed (argon, green and red traces) phosphate
buffer, as indicated.
(G) Fluorescence changes of purified liver mitoplasts after sequential additions of H2DCFDA, 0.5 mM ascorbate, 0.2 mM TMPD, and p66Shc
(red) or control buffer (black).indicating that the ET kinetics of p66Shc is accelerated
by cyt c. Therefore, it appears that p66Shc executes a
redox reaction with cyt c under the CV experimental
conditions.
We then investigated the effect of p66Shc on the re-
dox status of cyt c by spectrophotometry. Addition of
p66Shc modified the absorbance spectrum of reduced
cyt c, provoking a slight shift of the γ peak and a reduc-
tion of the amplitude of the α peak (Figure 3C). These
modifications are consistent with a strong interaction
between p66Shc and the prosthetic group of cyt c, and
the partial oxidation of cyt c. Analysis of the kinetics of
absorbance at 550 nm (α peak) revealed that the effect
of p66Shc on cyt c oxidation status is dose dependent
and comparable to that of purified yeast COX (Figure
3D). Together, these findings indicate that p66Shc is a
redox protein that oxidizes cyt c in vitro.
Electron Transfer between p66Shc and Cyt c
Generates Hydrogen Peroxide In Vitro
We then investigated whether p66Shc oxidizes
H2DCFDA when reacting with cyt c. Addition of p66Shc
to reduced cyt c did not provoke H2DFCDA oxidation
(data not shown). A significant fluorescence boost from
oxidized H2DCFDA was, instead, recorded in the pres-
ence of copper (but not zinc or iron) ions (Figure 3E;
red trace), indicating that, in vitro, the copper atom cat-
alyzes generation of free radicals from the redox center
of the p66Shc-cyt c complex. Notably, under anoxic
conditions, H2DCFDA oxidation was significantly de-
creased, suggesting a role for oxygen intermediates in
this process (Figure 3E; dashed trace). Since H2DCFDA
oxidation is specifically sensitive to H2O2, these data
suggest that this is the molecular species that forms
during the reaction.
To obtain a direct proof that H2O2 is generated during
the electrochemical reaction of p66Shc with cyt c, we
measured current generation at 650 mV (which corres-
ponds to the oxidation potential of H2O2) in an electrode-
confined p66Shc-cyt c system (Callegari et al., 2004).
P66Shc and cyt c were entrapped within a conducting
polymeric film and immobilized onto a glassy carbon
electrode. The coated electrode was then transferred
into an air- or argon-saturated phosphate buffer and a
−100 mV potential applied for 150 s (this potential in-
duces the continuous reduction of the p66Shc-cyt c
complex, has no direct effect on molecular oxygen, and
allows accumulation of oxygen radicals, if formed, in
the gel; accumulation step, Figure 3F). Analysis of cur-
rent generation at −100 mV revealed early oxygen
reduction current generated by the p66Shc/cyt c
electrode, only in the presence of air-saturated buffer
(Figure 3F; left panel). After switching of the electrode
potential to 650 mV (to measure accumulated H2O2; de-
tection step, Figure 3F), current was recorded specific-right panel). Furthermore, when the initial potential was
set at +100 mV (which cannot reduce the p66Shc/cyt c
redox center), neither catalytic oxygen reduction nor
H2O2 oxidation was detected (data not shown). To-
gether, these results provide direct demonstration that
ET between p66shc and cyt c leads to oxygen reduction
and formation of H2O2.
P66Shc Generates Hydrogen Peroxide
from Reduced Cyt c In Vivo
We then investigated whether, in vivo, the ETC site of
p66Shc-induced ROS production is compatible with the
described in vitro activity of p66Shc on reduced cyt c.
To this end, mitochondria were treated with ascorbate/
N,N#-tetramethyl-p-phenyldiamine (TMPD) in the ab-
sence of energetic substrates. Under these experimen-
tal conditions, mitochondrial respiration is supported
by reduction of cyt c (by TMPD), while complexes I–III
remain inactive. As expected, since the ETC sites of
ROS production are excluded in this system, ascor-
bate/TMPD-treated mitochondria did not generate
detectable ROS (Figure 3G; black trace). Addition of re-
combinant p66Shc, instead, induced H2DFCDA oxida-
tion, indicating that p66Shc is able to generate ROS by
acting downstream to reduced cyt c. Consistently,
p66Shc did not increase ROS generation induced by
inhibitors of complexes I (rotenone) or III (ant A) (Fig-
ure S4).
Mapping of the Redox Center of p66Shc
To map the region of p66Shc interacting with cyt c, we
compared, by ELISA, the cyt c binding properties of
p66Shc with those of p52Shc or p46Shc, which are not
involved in the regulation of ROS and apoptosis (Mig-
liaccio et al., 1999). Increasing amounts of coated cyt
c (0.25–4 g) were incubated with increasing amounts
of Shc proteins (0.08–4 g) and bound proteins re-
vealed with anti-Shc antibodies. The p66Shc-cyt c asso-
ciation was dose dependent at each concentration of
the two proteins (Figure 4B). A residual binding activity
(about 10%) was detected for p52Shc, while p46Shc did
not bind at all, suggesting that the N-terminal region of
p66Shc (CH2-PTB) is involved in cyt c binding.
To narrow down the cyt c binding region of p66Shc,
we expressed various portions of the CH2-PTB region
as GST fusion proteins (Figure 4C) and measured their
ability to recover cyt c from cellular lysates through
pull-down experiments. Results showed that a 52
amino acid region N terminal to the PTB domain is criti-
cal for the binding to cellular cyt c (denominated CB,
for cyt c binding; Figures 4A and 4C). This region is
highly conserved among the known p66Shc vertebrate
orthologs (Figure 4D) and contains glutamic (E125,
E132, E133) and tryptophan (W134 and W148) residues,
which, in the context of COX IV and yeast cyt c peroxi-
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228Figure 4. Mapping of the p66Shc Cyt c-Interacting Region
(A) Modular organization of Shc proteins (p66, p52, p46) and p66Shc mutants (qq and f ). The positions of the qq and f mutations are indicated
within the CB region.
(B) ELISA binding assay of recombinant p66Shc, p52Shc, p46Shc, p66Shcqq, and p66Shcf proteins added at different concentrations to dish
wells preadsorbed with different concentrations of cyt c, as indicated.
(C) In vitro pull-down experiment (right panel) using MEF lysates and the schematized (left panel) portions of p66Shc expressed in bacteria as
GST fusion proteins. Recovered proteins were analyzed by Western blotting using anti-cyt c antibodies.
(D) Amino acid sequence of the p66Shc N-terminal region. Amino acid sequence alignment of the CH2-PTB N-terminal regions (aa 1–155) of
the available p66Shc vertebrate horthologs. Identities are highlighted in gray. The most conserved region (CB) is boxed in red. The relevant
glutamic (E132 and E133) and triptophan (W134) residues are indicated in the sequence (by asterisks and circle, respectively) and in the
p66Shc modular organization scheme below.
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229with cyt c (Zhen et al., 1999). We engineered similar
mutations within p66Shc (p66ShcE132Q-E133Q muta-
tion, p66Shcqq; p66ShcW134F mutation, p66Shcf ) and
evaluated their effects on the ability of the protein to
bind cyt c, to transfer electrons, and to stimulate mito-
chondrial ROS generation. Notably, both qq and f muta-
tions abrogated the ability of recombinant p66Shc to
bind cyt c, as revealed by ELISA and pull-down experi-
ments (Figures 4B and 4C).
The CV curves of the p66Shcqq and p66Shcf mutants
showed symmetric peaks with redox potentials of −151
mV and −140 mV, respectively (Figures 5A and 5B).
These values are markedly lower than that of wt p66Shc
(−35 mV), suggesting that the E132-E133 and W134 res-
idues influence the p66Shc redox properties. In the pres-
ence of cyt c, the CV responses of both mutant proteins
resulted in two asymmetric peaks (Figures 5A and 5B),
which could be easily deconvoluted into two compo-
nents associated to the ET processes of cyt c (17 mV;
Figures 5A and 5B, green traces) and the p66Shcqq
(−150 mV; Figure 5A, orange trace) or p66Shcf (−141 mV;
Figure 5B, pink trace) mutants. The detection of sepa-
rated ET processes is consistent with a decreased in-
teraction between the two p66Shc mutants and cyt c,
as also revealed by ELISA and pull-down experiments
(Figures 4B–4D). Therefore, both properties of execut-
ing ET and interacting with cyt c are impaired in the qq
or f mutants of p66Shc, suggesting that the E132-E133
and W134 residues of p66Shc concur in the formation
of its redox center and cyt c binding surface.
We then compared the ability of p66Shc, p66Shcqq,
and p66Shcf to regulate production of ROS in vitro and
in vivo. Addition of recombinant p66Shcqq and p66Shcf
to digitonin-treated mitochondria did not increase
H2DCFDA oxidation (Figure 5C). Likewise, expression
of p66Shcqq and and p66Shcf into p66Shc−/− MEFs did
not increase the cellular fluorescence of H DCFDA-Figure 5. Impaired Redox Properties of
p66Shc Mutants Defective for Cyt c Binding
(A) Voltammograms of cyt c (green), p66Shcqq
(orange), and p66Shcqq + cyt c (black).
(B) Voltammograms of cyt c (green), p66Shcf
(pink), and p66Shcf + cyt c (black).
(C) Fluorescence changes of purified liver
mitoplasts during the sequential additions of
H2DCFDA; succinate; and buffer (ctrl, black),
p66Shc (red), p66Shcqq (orange), or p66Shcf
(violet) proteins.
(D) Ratio of the H2DCFDA mean fluorescence,
obtained by FACS analysis of p66Shc−/−
MEFs after infection with control, p66Shc,
p66Shcqq, or p66Shcf retroviruses; results are
the average ± SEM of three experiments.2stained cells (Figure 5D). Therefore, mutations that im-
pair the p66Shc redox center also inactivate the ability
of p66Shc to stimulate ROS generation in vivo.
Mutation of the Redox Center of p66Shc Impairs
its Ability to Mediate Mitochondrial Apoptosis
We then investigated whether the function of p66Shc to
regulate mitochondrial apoptosis depends on its elec-
trochemical properties, using the p66Shcqq mutant. To
ensure that the qq mutation had not interfered with
other functions of p66Shc, we first evaluated the ability
of the two neighboring domains (PTB and CH2) to bind
activated receptors and undergo phosphorylation after
oxidative stress, respectively, and the property of
p66Shcqq to localize within mitochondria. In the context
of the qq mutation, the p66Shc PTB domain maintained
its ability to bind activated EGF receptors (Figure 6A).
Likewise, p66Shcqq was efficiently phosphorylated on
serine following expression into p66Shc−/− MEFs and
treatment with H2O2 (Figure 6B). Like the wt protein,
p66Shcqq localizes within mitochondria (Figure 6C).
Mitochondrial p66Shc is PK resistant (Figure 6D); it is
released by digitonin treatment (Figure 6E) and forms a
complex with mtHsp70, from which it dissociates after
proapoptotic stimuli (Figure 6F).
We then measured the ability of the p66Shcqq mutant
to regulate mitochondrial PT in vitro and apoptosis in vivo.
P66Shcqq was unable to induce swelling of digitonized
mitochondria (Figure 7A), nor did it restore the apo-
ptotic response of p66Shc−/− MEFs upon treatment with
H2O2 or staurosporine, as measured by cyt c release
(Figure 7B), caspase activation (Figure 7C), and cell via-
bility (Figure 7D). Notably, CsA inhibited the ability of
reexpressed p66Shc to restore mitochondrial apoptosis
following H2O2 (Figure 7E) or staurosporine (data not
shown), supporting the theory that a functional PT is
needed for the proapoptotic activity of p66Shc. It ap-
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230Figure 6. Receptor Binding, Phosphorylation,
Localization, and Hsp70 Association of the
p66Shc Redox Mutants
(A) In vitro pull-down experiment using
lysates of MEFs and treated or not with
EGF, and GST, GST-PTBp66Shc, or GST-
PTBp66Shcqq. Recovered proteins were ana-
lyzed by WB using anti-EGFR antibodies.
(B) P66Shc−/− MEFs were reconstituted with
p66Shc or p66Shcqq by retroviral-mediated
gene transfer and treated or not with H2O2.
Anti-Shc immunoprecipitates were analyzed
by WB using antibodies against phosphory-
lated p66Shc (upper panel) or total pool of
p66Shc (lower panel).
(C) WB analysis of subcellular fractions from
p66Shc−/− MEFs reexpressing p66Shc or
p66Shcqq, using the indicated antibodies.
(D) Mitochondria (Mt) and ER-enriched frac-
tions (ER) were treated with PK and analyzed
by WB with indicated antibodies.
(E) MEFs mitochondrial fractions (as in [C])
were treated with the indicated concentra-
tions of digitonin. After centrifugation, pel-
lets (P) and supernatants (S) were analyzed
by WB.
(F) MEFs mitochondrial fractions (as in [C])
were immunopreciptated with anti-p66Shc
antibodies. Specific immunoprecipitates were
analyzed by WB using anti-mtHsp70 (upper
panel) or anti-p66Shc (lower panel) antibodies.pears, therefore, that mutation of the p66Shc redox cen- c
nter abrogates the functions of p66Shc to induce mito-
chondrial PT in vitro and to mediate cellular apoptosis s
wafter stress.
t
sDiscussion
m
mThe present findings provide a mechanistic explanation
mfor the proapoptotic function of p66Shc and support a
(model whereby p66Shc generates H2O2 within mito-
pchondria, which, in turn, induces opening of the PTP
mand cellular apoptosis (Figure 8). ROS production by
ap66Shc appears to be a specialized function whereby
melectrons are subtracted from the mitochondrial ETC to
pcatalyze the partial reduction of molecular oxygen. This
Fis the first demonstration that the mitochondrial respi-
pratory chain can generate ROS not only accidentally
tbut also through a specific enzymatic system. In this
tcontext, p66Shc can be regarded as an atypical signal
ctransducer that converts proapoptotic into redox signals.
eIn vitro and in vivo experiments demonstrated that
ep66Shc oxidizes cyt c and generates H2O2. Therefore, a
ifraction of the mitochondrial electron flow, which is
(mostly used by COX to reduce oxygen to water, is devi-
aated from cyt c by p66Shc for the production of ROS
m(Figure 8). P66Shc expression, however, does not influ-
wence the mitochondrial transmembrane potential under
msteady-state conditions, while it is indispensable for its
scollapse following proapoptotic signals (Orsini et al.,
s2004). These findings are compatible with the existence
of two functional states of p66Shc: inactive, under basal ronditions, and active, after proapoptotic signals. A
umber of modifications of p66Shc have been de-
cribed, which occur within minutes after treatment
ith various proapoptotic signals and might lead to ac-
ivation of p66Shc: the cytosolic pool of p66Shc becomes
erine phosphorylated (Migliaccio et al., 1999), the
itochondrial pool of p66Shc is released from a high
olecular weight complex (Orsini et al., 2004), and both
itochondrial and cytosolic p66Shc pools are increased
Trinei et al., 2002; Pacini et al., 2004). In the case of
hosphorylation, genetic evidence indicates that this
odification is required for the ability of p66Shc to medi-
te apoptosis (Migliaccio et al., 1999). The underlying
echanism, however, is unknown. The mitochondrial
ool of p66Shc is not serine phosporylated (E.M. and
.O., unpublished data), and significant translocation of
66Shc from cytosol to mitochondria does not occur af-
er proapoptotic signals (Orsini et al., 2004), suggesting
hat serine phosphorylation might serve other, nonmito-
hondrial activities of p66Shc that are also needed to
xert its proapoptotic function. Mitochondrial p66Shc
xists within a high-molecular-weight complex, which
ncludes members of the TIM-TOM import complex
TIM44, TIM20, TIM23, and mtHsp70; Orsini et al. [2004]
nd E.M. and F.O., unpublished data). The p66Shc-
tHsp70 complex is destabilized following treatment
ith proapoptotic signals, leading to the release of
onomeric p66Shc. Since recombinant p66Shc pos-
esses constitutive redox activity, it is tempting to
peculate that association with the TIM-TOM complex
esults with the inactivation of p66Shc and that pro-
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231Figure 7. The p66Shcqq Mutant Does Not In-
duce PT, Nor Does It Activate Apoptosis
(A) Absorbance changes of digitonized liver
mitochondria pretreated with Ca2+ and
added of p66Shc (red trace) or p66Shcqq (or-
ange) proteins.
(B) WT and p66Shc−/− MEFs infected with con-
trol, p66Shc, or p66Shcqq retroviruses were
treated with 2 M staurosporine and, after 6
or 12 hr, cytosolic fractions analyzed by WB
(left panels). Cytosolic cyt c was analyzed by
ELISA in the same cells after 6 hR treatment
with 2 M staurosporine or 800 M H2O2
(right bar graph).
(C and D) The same cells as in (B) were
treated with 2 M staurosporine or 800 M
H2O2 and analyzed for caspase-3 activation
(by flow cytometry using antibodies against
cleaved caspase-3; [C]) or trypan blue (D).
(E) The same cells as in (B) were treated with
H2O2 and 5 m CsA and analyzed by trypan
blue. Results represent the mean of triplicate
cultures ± SEM.providing the molecular basis for a function of p66ferent proapoptotic mechanisms may lead to increased
Figure 8. Model of p66Shc Redox Activity
during Mitochondrial Apoptosis
Proapoptotic signals induce release of p66Shc
from a putative inhibitory complex. Active
p66Shc then oxidizes reduced cyt c (red) and
catalyzes the reduction of O2 to H2O2. PTP
opening by H2O2 then leads to swelling and
apoptosis. NADH-cyt b5 reductase is indi-
cated as additional putative source of re-
duced cyt c.apoptotic signals activate p66Shc by releasing it from
this inhibitory complex.
A further mechanism of regulation of the proapo-
ptotic function of mitochondrial p66Shc might be linked
to its intrinsic redox properties. Since the calculated
Keq of the [p66Shc] + [cyt c]4 [p66Shc]− + [cyt c]+ redox
reaction is 0.1, cyt c oxidation by p66Shc is unfavored
when reduced cyt c is present at a concentration com-
parable to p66Shc. The reaction might, instead, occur if
an excess of reduced cyt c is present, a condition that
is achieved when COX activity is decreased (e.g., dur-
ing hypoxia) or by physiological inhibition by nitric ox-
ide (NO) (Sarti et al., 2003). Notably, reduced cyt c might
also accumulate during tBid/Bax-induced apoptosis,
since both molecules induce remodeling of the inner
membrane and increase of free intermembrane cyt c
(Scorrano et al., 2002), which is then fully reduced by
the outer membrane rotenone-insensitive NADH-cyt b5
reductase (Bernardi and Azzone, 1981). Therefore, dif-concentrations of reduced cyt c, thus firing the ET reac-
tion of p66Shc (Figure 8).
The levels of intracellular ROS and of oxidation-dam-
aged DNA are significantly reduced in p66Shc−/− primary
cultures (fibroblasts, endothelial cells, lymphocytes;
Nemoto and Finkel [2002]; Trinei et al. [2002]; Zaccag-
nini et al. [2004]; Pacini et al. [2004]). Likewise, markers
of oxidative stress (8-oxo-guanosine, isoprostane, nit-
rotyrosine) are decreased in tissues from p66Shc−/− mice
(Trinei et al., 2002; Napoli et al., 2003; Francia et al.,
2004), suggesting that p66Shc might regulate ROS pro-
duction also in the absence of acute (proapoptotic)
stress signals and that a fraction of intracellular ROS
(and of oxidative stress) depends, under basal condi-
tions, on the expression of p66Shc. Since p66Shc is acti-
vated by virtually every type of stress, the basal pro-
duction of ROS by p66Shc may reflect its moderate
activation by chronic stress. The redox balance has
profound effects on metabolism and transcription, thus
Shc
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232Ain the cellular adaptation to chronic stress. Regulation
of redox equilibrium and apoptosis by p66Shc might
Wequally contribute to its effect on life span.
c
fExperimental Procedures
c
fCells, Vectors, and Antibodies
hMEFs were treated with 2 M staurosporine or 800 M H2O2. Cyto-
solic cyt c was measured after 6 hr by ELISA and after 6/12 hr by
WB of cytosolic fractions; anti-caspase-3 positive cells after 6 hr, R
by FACS; and cell survival after 20 hr, by trypan blue. Intracellular R
ROS were measured incubating cells for 30 min with 10 M A
H2DCFDA (Molecular Probes) in complete culture medium; cells P
were then recovered and suspended in PBS for FACS analysis. Mi-
toplast (0.5 mg/ml) or 0.4 mg/ml mitochondrial suspension and 30
RM DH2CFDA were sequentially added to a spectrofluorimetric cu-
vette. Fluorescence (excitation wavelength [ex.] 498; emission
Awavelength [em.] 525) was registered using a Perkin Elmer Ls55
mspectrofluorimeter at 25°C. Anti-p66Shc antibodies have been de-
Cscribed (Orsini et al., 2004). Antibodies against caspase-3,
mtHsp70, cytHsp70, calnexin, porin, phosphorylated p66Shc Ser36 B
residue, phosphotyrosine, and cyt c were obtained from commer- B
cial sources. The p66Shcqq and f mutants were generated using the c
QuikChange Site-Directed Mutagenesis Kit (Stratagene) and 4
cloned into the PINCO vector (Migliaccio et al., 1999).
B
sCellular Subfractionation, Mitochondria,
Band Mitoplast Preparation
BCell lysates were subjected to differential centrifugations to sepa-
crate nuclei (700 rgf), mitochondria (8000 rgf), and the endoplasmic
reticulum (15,000 rgf). Mice were intraperitoneally injected with 2 1
mg CCl4/g of body weight CCl4 20 hr before liver collection. Each B
mitochondrial preparation was assayed for respiration by using a d
Clark type oxygraph and swelling, as described (Petronilli et al.,
C1994), with minor modifications (OD620; 0.4 mg/ml mitochondrial
dsuspension with 5 mM succinate as substrate). Mitoplasts were
1obtained by hypotonic shock (1:10 dilution in deionized water for 5
Cmin on ice).
G
FProtein Film Voltammetry
iWe used a three electrode cell composed of a saturated calomel
Melectrode (reference), platinum spiral wire (counter electrode), and
gold disk (working electrode). The SAM was formed by soaking the C
gold electrode for 5 hr in 100 M 11-mercaptoundecanoic acid. o
Purified horse cyt c (Sigma), p66Shc, p66Shcqq, or p66Shcf solutions
Cwere deposited on the electrode surface and left to evaporate
pslowly. Measurements were performed in phosphate buffer and
lLiClO4 at constant ionic strength (100 mM). Before each experi-
1ment, the electrolyte solution was purged with argon transistor
D(lower than 1 ppm O2), and the voltammetric curves were recorded
pmaintaining an argon blanket over the solution. CV experiments
were carried out at 5–50 mV/s with an Autolab Model PGSTAT 30 at D
25°C. Protein midpoint potentials (E1/2) were calculated as average (
between the potential of oxidation (Epa) and reduction (Epc) peaks. n
l
Recombinant Proteins, ELISA, and In Vitro Binding Assay
FAll recombinant proteins were produced in E. coli as GST fusion
vproteins. GST was removed by prescission treatment after affinity
Vcolumn purification. For in vitro binding assays, total protein ly-
tsates (1 mg) were incubated for 2 hr at 4°C with 10 g of the appro-
2priate GST fusion protein. ELISA plates were coated with 4, 1, or
G0.25 g purified horse cyt c (Sigma) by using a 4 g/ml coating
csolution in carbonate buffer (0.1 ml/well). After washing with PBS,
different concentrations of recombinant Shc proteins were added G
to each well and incubated for 2 hr at 37°C. Binding was revealed d
using an anti SH2-SHC antibody (Transduction Laboratories) and M
horseradish peroxidase-conjugated anti-rabbit antibodies. Bound l
antibodies were detected using the TMB detection reagent (SIGMA).
L
t
gSupplemental Data
2Supplemental Data include four figures and can be found with this
Marticle online at http://www.cell.com/cgi/content/full/122/2/221/
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